JCS cover for a new function of tumor suppressive histone variant identified
The histone variants macroH2A are tumor suppressors that are down regulated or lost in several solid cancers and leukemia
Members of the Chronic Lymphocytic Leukemia (CLL) working group of campus IJC-Badalona have just published a work in the prestigious “American Journal of Hematology”.
This work was led by Dr. Maria Joao Baptista, Dr. Isabel Granada and Dr. Francesc Solé.
Agreement between the IJC-IGTP-ICO: an essential step for research into leukaemia at the Can Ruti campus
The Germans Trias i Pujol Institute on Health Sciences Foundation (IGTP), the Catalan Institute for Oncology (ICO) and the Josep Carreras Leukaemia Research Institute (IJC) have signed a collaboration agreement to promote scientific research into leukaemia and other malignant blood diseases
Novel insights into the molecular pathogenesis of aggressive lymphoma subtypes and their clinical implications
In the past March 10th, Professor Georg Lenz, from the Translational Oncology Department of Medicine A, Universitätsklinikum Münster, was at the campus IJC-Badalona to gave a talk entitle “Novel insights into the molecular pathogenesis of aggressive lymphoma subtypes and their clinical implications”.
Non-AUG start codons responsible for ABO weak blood group alleles on initiation mutant backgrounds
Dr. Emili Cid, a postdoctoral fellow at the Immunohematology and Glycobiology Group of the Josep Carreras Leukaemia Research Institute has published a paper in the journal Nature Scientific Reports.
The Immunohematology and Glycobiology Group describe the biology of the rare Forssman antigen (FORS1) associated with some cancers
Miyako Yamamoto and her colleagues at the Immunohematology and Glycobiology Group at the Josep Carreras Leukaemia Research Institute have published a paper entitled “Crosstalk between ABO and Forssman (FORS) blood group systems: FORS1 antigen synthesis by ABO gene-encoded glycosyltransferases” in the journal Scientific Reports.
A new Achilles heel discovered in leukemia stem cells in acute myeloid leukemia
A young researcher in the Risueño group publishes a paper in Leukemia
IJC Researcher co-authors an important review paper
Marcus Buschbeck and Sandra Hake have published an article on the state of the art in histone biology in Nature Reviews Molecular Cell Biology.
The IJC to lead one of the ten Integrated Projects of Excellence awarded by Instituto Carlos III
A multidisciplinary team, made up of groups from various organisations will focus on three major cancers: advanced colorectal and lung cancers treated with chemotherapy and high-risk myelodysplastic syndrome (MDS) treated with azacitidine.